← Back to Clinical Trials
RecruitingPhase 4NCT06918054
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
ConditionLeukaemia (Acute)
SponsorAin Shams University
Study TypeINTERVENTIONAL
PhasePhase 4
Enrollment42
SexALL
Min Age2 Years
Max Age18 Years
Start Date2023-11-17
Completion2025-05
All Conditions
Interventions
Dietary modificationSupplementation of omega 3 fatty acids
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.
Eligibility Criteria
Inclusion Criteria: Children and adolescents aged from 2 to 18 years newly diagnosed with acute lymphoblastic leukemia during induction phase of chemotherapy treated at Ain Shams Exclusion Criteria: Known chronic liver disease.